Why global pharma is worth a look
Why global pharma is worth a look
General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.
About this video
Positive earnings and a revaluation have helped the US pharma sector outperform in recent weeks. Alastair MacLeod from Wheelhouse Partners has been flagging for a while that the sector is incredibly cheap, and a good inflation hedge to boot. We speak with him about the drivers and how the vaccine rollout and profit vs not-for-profit will potentially impact performance going forward. Interestingly, Alastair examines big pharma through an ESG lens as well. Australian investors take note, if you want to gain exposure to big profits from big pharma, Alistair says you'll have to look overseas.
More like this
59:22
the callthe call: 22nd October | MSFT GE V NFLX MNST SQM MRVL AS JNJ MCD22 Oct 202652:56
the callthe call: 24th September | global stocks | MSFT MRNA TSM MRK AMZN PI CLS GOOG BAC WMT24 Sept 20267:26
Annabelle's favourite stock you've never heard of24 Aug 202613:08
the global viewThe out‑of‑favour large‑caps Ira is buying into4 June 2026